Combination of HGF Inhibitor and EGF Inhibitor to Treat Cancer
- 专利权人:
- John Laterra
- 发明人:
- John Laterra,Bachchu Lal,Kyung Jin Kim
- 申请号：
- US12963595
- 公开号：
- US20120076775A1
- 申请日:
- 2010.12.08
- 申请国别(地区):
- US
- 年份:
- 2012
- 代理人:
- 摘要：
- The present invention is directed toward a method of treating cancer by administering to a patient an inhibitor of Hepatocyte Growth Factor and an inhibitor of, e.g., Epidermal Growth Factor.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- MONOCLONAL ANTIBODIES TO HEPATOCYTE GROWTH FACTOR
- MONOCLONICAL ANTISTS AGAINST FIBROBLASTIC GROWTH FACTOR 2
- Monoclonal Antibodies to Hepatocyte Growth Factor
- TRATAMIENTO DE CANCER CON DOSIS ELEVADAS DE PROTEINAS DE FUSION DEL RECEPTOR DEL FACTOR DE CRECIMIENTO DE FIBROBLASTOS 1 (FGFR1) SOLUBLES.
- СПОСОБ СТИМУЛЯЦИИ РЕГЕНЕРАТИВНЫХ ПРОЦЕССОВ В ИШЕМИЗИРОВАННЫХ ТКАНЯХ
